🇺🇸 FDA
Patent

US 11324725

Compositions and methods for the inhibition of pruritus

granted A61KA61K31/395A61K31/42

Quick answer

US patent 11324725 (Compositions and methods for the inhibition of pruritus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/395, A61K31/42, A61K31/422, A61K31/4439